• 2001 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Dr. Ma' clinical and research interests are focused on chronic lymphoid malignancies,including chronic lymphocytic leukemia and non-Hodgkin lymphoma. Dr. Ma directs the clinical and translational research initiatives in chronic lymphocytic leukemia (CLL) to develop and study novel treatment agents for the treatment of CLL. Her translational investigations have included novel biologic agents, mechanisms of drug resistance and immunotherapy. Dr. Ma is the Principal Investigator for a number of investigator-initiated and industry-sponsored clinical trials studying new exciting treatments agents for CLL and lymphoma. She collaborates with investigators at Northwestern University, other US institutions and international institutions in developing novel therapeutic approaches in hematologic malignancies.

Certifications and Licenses

Internal Medicine
Medical Oncology

Training Experience

2005Residency, Resurrection Hospitals
2008Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

PhD, Northwestern University Feinberg School of Medicine

… → 2000

MD, Beijing Medical University

… → 1994


  • Biologic Therapies
  • Blood Cancer (leukemia and lymphomas)
  • Chronic Lymphocytic Leukemia
  • Hematology
  • Non-Hodgkin's Lymphoma
  • Oncology

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 14 Similar Profiles
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Dyneins Medicine & Life Sciences
Dictyostelium Medicine & Life Sciences
Waldenstrom Macroglobulinemia Medicine & Life Sciences
Signal Transduction Medicine & Life Sciences
Leukocytes Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2007 2024

Research Output 1999 2019

1 Citation (Scopus)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan-Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 othersMato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N., Dwyer, M. A. & Sundar, H., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Lymphoma, Large B-Cell, Diffuse
Hodgkin Disease
Atrial Fibrillation
B-Cell Chronic Lymphocytic Leukemia
Heart Diseases
B-Cell Chronic Lymphocytic Leukemia
Drug Therapy
3 Citations (Scopus)

Frontline Therapy of CLL: Evolving Treatment Paradigm

Boddy, C. S. & Ma, S., Apr 1 2018, In : Current Hematologic Malignancy Reports. 13, 2, p. 69-77 9 p.

Research output: Contribution to journalReview article

B-Cell Chronic Lymphocytic Leukemia
Immunoglobulin Heavy Chain Genes
Phase III Clinical Trials
7 Citations (Scopus)

A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma

Holkova, B., Yazbeck, V., Kmieciak, M., Bose, P., Ma, S., Kimball, A., Tombes, M. B., Shrader, E., Wan, W., Weir-Wiggins, C., Singh, A., Hogan, K. T., Conine, S., Sankala, H., Roberts, J. D., Shea, T. C. & Grant, S., Jun 3 2017, In : Leukemia and Lymphoma. 58, 6, p. 1349-1357 9 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Cutaneous T-Cell Lymphoma
B-Cell Lymphoma
B-Cell Chronic Lymphocytic Leukemia
Maximum Tolerated Dose